Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

The FDA cleared the Epithelial Thickness Module for the Anterion cornea app from Heidelberg Engineering, according to a press ...

The FDA granted rare pediatric disease designation to VG901 for the treatment of retinitis pigmentosa caused by mutations in ...

JJ is a 75-year-old man who presents to the office after his wife made an appointment for him this morning for evaluation of ...

Some megatrends in health care are occurring that deserve our attention. We already know that as much as one-third of the U.S ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

The CDC has awarded Weill Cornell Medicine a 5-year, $2.3 million grant to advance equitable access to care for young ...

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...

Factors such as non-Hispanic Black race and all-cause mortality within 90 days after tuberculosis, or TB, diagnosis, as well ...

High job strain was significantly associated with sleep disturbances over a follow-up of nearly 10 years, highlighting the ...

The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...